Dow Chemical’s Acquisition of Rohm & Haas

Cravath represented the Haas Family Trusts in connection with Rohm and Haas Company’s definitive agreement with The Dow Chemical Company, under which Dow will acquire all the outstanding shares of Rohm and Haas common stock for $78.00 per share in cash, for an aggregate transaction value of approximately $18.8 billion. The Haas Family Trusts collectively control approximately 33% of the outstanding Rohm and Haas common stock. The transaction remains subject to approval by the shareholders of Rohm and Haas, as well as customary conditions and approval of appropriate regulatory authorities.

The lawyers involved in this matter are partner Richard Hall, associate Marvin B. Tagaban and summer associate Jennifer M. Sasso on corporate matters; partner Daniel L. Mosley and associate Kenneth C. Halcom on trusts and estate matters; and partner Elizabeth L. Grayer and associate Robin C. Landis on antitrust matters. The deal was announced on July 10, 2008.